Working… Menu

Randomized, Single-dose, Crossover Study of 4 Decitabine and Tetrahydrouridine (EPI01) Formulations in Healthy Subjects (EPI01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03828084
Recruitment Status : Completed
First Posted : February 4, 2019
Last Update Posted : May 9, 2019
Information provided by (Responsible Party):
EpiDestiny, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2, 2019
Actual Study Completion Date : May 3, 2019